35.95 CHF

Opening hours: 09:00 - 17:20 (Central European Standard Time: 11/22/2024 3:01:03 AM)
Exchange closed, opens in 5 hours 58 minutes
-0.83 CHF (-0.83%)
-5.39 CHF (-5.39%)
-1.91 CHF (-1.91%)
-11.45 CHF (-11.45%)
-3.07 CHF (-3.07%)
-23.48 CHF (-23.48%)
57.15 CHF (57.15%)
477.36 CHF (477.36%)

About BB Biotech AG

Market Capitalization 1.99B

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Headquarters (address)

Seestrasse 16

Küsnacht CH-8700

Switzerland

Phone41 44 2676700
Websitehttps://www.bbbiotech.ch/en/bb-biotech/
Employees10
SectorHealthcare
IndustryBiotechnology
TickerBION
ExchangeSwiss Stock Exchange
CurrencyCHF
52 week range35.45 - 49.80
Market Capitalization1.99B
Dividend yield forward22.22 %
Dividend yield forward Switzerland (ID:153, base:169) 13.52 %
P/E trailing15.85
P/E forward9.31
Price/Sale-9.97
EPS-3.77
EPS Switzerland (ID:153, base:185) 29.31

Forward Annual Dividend Yield

Forward Annual Dividend Yield: BB Biotech AG has raised their dividend 22.22 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: BB Biotech AG has raised their dividend 12.22 years in a row. This is above the 10.156100 year average in the 'Biotechnology' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: BB Biotech AG has raised their dividend 22.22 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: BB Biotech AG has raised their dividend 12.22 years in a row. This is above the 10.156100 year average in the 'Biotechnology' industry

CleverShares.com|
2024 ©

1.0.9089.36765